Precision Biosciences (DTIL) Amortizatization of Intangibles (2020 - 2026)
Precision Biosciences' (DTIL) quarterly Amortizatization of Intangibles came in at $117000.0 in Q1 2026, down 11.36% year-on-year from $132000.0 in Q1 2025, and up 431.82% on a QoQ basis from $22000.0 in Q4 2025.
Precision Biosciences (DTIL) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 7 years of Amortizatization of Intangibles data on file, last reported at $117000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 11.36% year-over-year to $117000.0 in Q1 2026; TTM through Mar 2026 was $171000.0, a 11.04% increase from a year earlier, with the FY2025 full-year figure at $186000.0, down 25.3% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $117000.0, up from $22000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for DTIL reached as high as $227000.0 in Q1 2024 and fell as low as -$27000.0 in Q3 2024.
- Historically, Amortizatization of Intangibles has averaged $71470.6 across 5 years, with a median of $52000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles jumped 1152.94% in 2023 and tumbled 151.92% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $85000.0 in 2022, then slumped by 37.65% to $53000.0 in 2023, then tumbled by 60.38% to $21000.0 in 2024, then advanced by 4.76% to $22000.0 in 2025, then surged by 431.82% to $117000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $117000.0 in Q1 2026, $22000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | 117,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 227,000.00 |
| Mar 31, 2024 | 227,000.00 |
| Dec 31, 2023 | 53,000.00 |
| Dec 31, 2023 | 53,000.00 |